152 related articles for article (PubMed ID: 18395972)
1. A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Abe M; Sugiura T; Takahashi M; Ishii K; Shimoda M; Shirasuna K
Cancer Lett; 2008 Aug; 266(2):163-70. PubMed ID: 18395972
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin CD82 represses Sp1-mediated Snail expression and the resultant E-cadherin expression interrupts nuclear signaling of β-catenin by increasing its membrane localization.
Lee MS; Byun HJ; Lee J; Jeoung DI; Kim YM; Lee H
Cell Signal; 2018 Dec; 52():83-94. PubMed ID: 30189244
[TBL] [Abstract][Full Text] [Related]
3. CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells.
Chigita S; Sugiura T; Abe M; Kobayashi Y; Shimoda M; Onoda M; Shirasuna K
Int J Oncol; 2012 Dec; 41(6):2021-8. PubMed ID: 23076981
[TBL] [Abstract][Full Text] [Related]
4. N-glycosylation of CD82 at Asn157 is required for suppressing migration and invasion by reversing EMT via Wnt/β-catenin pathway in colon cancer.
Zhu L; Chen Y; Du H; Cong Y; Yan W; Ma K; Huang X
Biochem Biophys Res Commun; 2022 Nov; 629():121-127. PubMed ID: 36116374
[TBL] [Abstract][Full Text] [Related]
5. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.
Takahashi M; Sugiura T; Abe M; Ishii K; Shirasuna K
Int J Cancer; 2007 Nov; 121(9):1919-1929. PubMed ID: 17621632
[TBL] [Abstract][Full Text] [Related]
6. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
Malik FA; Sanders AJ; Jiang WG
Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
[TBL] [Abstract][Full Text] [Related]
7. CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer.
Ma Z; Gao Y; Liu W; Zheng L; Jin B; Duan B; Xie H; Guo P; Zeng J; Wang K; Xu S; Wang X; He D; Li L
Dis Markers; 2020; 2020():8899924. PubMed ID: 33204367
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
10. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
Marjon KD; Termini CM; Karlen KL; Saito-Reis C; Soria CE; Lidke KA; Gillette JM
Oncogene; 2016 Aug; 35(31):4132-40. PubMed ID: 26592446
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1.
Odintsova E; Sugiura T; Berditchevski F
Curr Biol; 2000 Aug; 10(16):1009-12. PubMed ID: 10985391
[TBL] [Abstract][Full Text] [Related]
13. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling.
Chairoungdua A; Smith DL; Pochard P; Hull M; Caplan MJ
J Cell Biol; 2010 Sep; 190(6):1079-91. PubMed ID: 20837771
[TBL] [Abstract][Full Text] [Related]
14. CD148 tyrosine phosphatase promotes cadherin cell adhesion.
Takahashi K; Matafonov A; Sumarriva K; Ito H; Lauhan C; Zemel D; Tsuboi N; Chen J; Reynolds A; Takahashi T
PLoS One; 2014; 9(11):e112753. PubMed ID: 25386896
[TBL] [Abstract][Full Text] [Related]
15. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
16. Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.
Scarpino S; Duranti E; Giglio S; Di Napoli A; Galafate D; Del Bufalo D; Desideri M; Socciarelli F; Stoppacciaro A; Ruco L
Thyroid; 2013 Sep; 23(9):1127-37. PubMed ID: 23617728
[TBL] [Abstract][Full Text] [Related]
17. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
Zhang XA; He B; Zhou B; Liu L
J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
[TBL] [Abstract][Full Text] [Related]
18. Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
Neumann E; Schwarz MC; Hasseli R; Hülser ML; Classen S; Sauerbier M; Rehart S; Mueller-Ladner U
Ann Rheum Dis; 2018 Nov; 77(11):1619-1626. PubMed ID: 29980577
[TBL] [Abstract][Full Text] [Related]
19. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
20. A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens.
Yoshihama N; Yamaguchi K; Chigita S; Mine M; Abe M; Ishii K; Kobayashi Y; Akimoto N; Mori Y; Sugiura T
PLoS One; 2015; 10(4):e0124743. PubMed ID: 25923697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
